Document

We consent to the incorporation by reference in the Registration Statement (Form S-8), filed on August 6, 2024, pertaining to the Amended and Restated Stock Incentive Plan of Emergent BioSolutions Inc. of our reports dated March 8, 2024, with respect to the consolidated financial statements and schedule of Emergent BioSolutions Inc. and subsidiaries and the effectiveness of internal control over financial reporting of Emergent BioSolutions Inc. and subsidiaries included in its Annual Report (Form 10-K) for the year ended December 31, 2023, filed with the Securities and Exchange Commission.